Brant Point Investment Management’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-25,000
Closed -$934K 151
2025
Q4
$934K Sell
25,000
-25,000
-50% -$1.02M 0.11% 122
2025
Q3
$2.02M Sell
50,000
-35,455
-41% -$1.17M 0.22% 92
2025
Q2
$2.18M Sell
85,455
-18,269
-18% -$398K 0.23% 84
2025
Q1
$2.22M Buy
+103,724
New +$2.32M 0.26% 91

Other funds holding PAHC

Brant Point Investment Management's PAHC Position: Q1 2026 in Review

Brant Point Investment Management sold out of Phibro Animal Health (PAHC) in Q1 2026, closing a stake of 25,000 shares — an estimated $934K sold.

Brant Point Investment Management first reported a position in PAHC in Q1 2025 and held it in 4 quarters. The position peaked at $2.22M in Q1 2025. 257 funds tracked by Wall St. Rank hold PAHC as of Q1 2026.

  • Brant Point Investment Management reported no remaining Phibro Animal Health position as of Q1 2026 after selling out during the quarter.
  • Brant Point Investment Management sold 25,000 Phibro Animal Health shares in Q1 2026, an estimated $934K.
  • Brant Point Investment Management first reported a position in Phibro Animal Health in Q1 2025 and held it in 4 quarters.
  • Brant Point Investment Management's Phibro Animal Health position peaked at $2.22M in Q1 2025.
  • 257 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2026.

Based on Brant Point Investment Management's 13F filing for Q1 2026, filed 14 May 2026.